1. Home
  2. RFM vs BYSI Comparison

RFM vs BYSI Comparison

Compare RFM & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFM
  • BYSI
  • Stock Information
  • Founded
  • RFM 2020
  • BYSI 2010
  • Country
  • RFM United States
  • BYSI United States
  • Employees
  • RFM N/A
  • BYSI N/A
  • Industry
  • RFM Finance/Investors Services
  • BYSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RFM Finance
  • BYSI Health Care
  • Exchange
  • RFM Nasdaq
  • BYSI Nasdaq
  • Market Cap
  • RFM 86.0M
  • BYSI 71.0M
  • IPO Year
  • RFM N/A
  • BYSI 2017
  • Fundamental
  • Price
  • RFM $13.89
  • BYSI $3.15
  • Analyst Decision
  • RFM
  • BYSI
  • Analyst Count
  • RFM 0
  • BYSI 0
  • Target Price
  • RFM N/A
  • BYSI N/A
  • AVG Volume (30 Days)
  • RFM 20.7K
  • BYSI 81.2K
  • Earning Date
  • RFM 01-01-0001
  • BYSI 08-11-2025
  • Dividend Yield
  • RFM 9.74%
  • BYSI N/A
  • EPS Growth
  • RFM N/A
  • BYSI N/A
  • EPS
  • RFM N/A
  • BYSI N/A
  • Revenue
  • RFM N/A
  • BYSI N/A
  • Revenue This Year
  • RFM N/A
  • BYSI N/A
  • Revenue Next Year
  • RFM N/A
  • BYSI N/A
  • P/E Ratio
  • RFM N/A
  • BYSI N/A
  • Revenue Growth
  • RFM N/A
  • BYSI N/A
  • 52 Week Low
  • RFM $12.89
  • BYSI $0.98
  • 52 Week High
  • RFM $16.41
  • BYSI $3.44
  • Technical
  • Relative Strength Index (RSI)
  • RFM 35.59
  • BYSI 72.10
  • Support Level
  • RFM $13.91
  • BYSI $2.73
  • Resistance Level
  • RFM $14.16
  • BYSI $3.44
  • Average True Range (ATR)
  • RFM 0.09
  • BYSI 0.33
  • MACD
  • RFM -0.02
  • BYSI 0.12
  • Stochastic Oscillator
  • RFM 3.61
  • BYSI 81.49

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Share on Social Networks: